Recent Updates
Recently added Catalysts
BSX Positive Sentiment

Boston Scientific announces conference call discussing second quarter 2025 results

Tuesday, July 1, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Boston Scientific Corporation will hold a conference call on July 23, 2025, to discuss its financial results for the second quarter ended June 30, 2025. The call will be led by CEO Mike Mahoney and CFO Jon Monson. A news release with the financial results will be issued prior to the call. The event will be accessible via a live webcast.
Price reaction · baseline $107.41 (2025-06-30 close) · hit pre-market · 1 other BSX headline(s) in the window, move may be shared
day 0 close · peak
-2.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Boston Scientific is hosting a conference call to discuss positive financial results.
  • The company continues to innovate in medical technologies.
  • The event will provide insights into business highlights.

Full Press Release Details

MARLBOROUGH, Mass.,July 1, 2025/PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial results and business highlights for the second quarter endedJune 30, 2025, onWednesday, July 23, 2025, at8:00 a.m. ET. The call will be hosted byMike Mahoney, chairman and chief executive officer, and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter onJuly 23prior to the conference call.
A live webcast and replay for the event will be accessible athttps://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston ScientificBoston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more atwww.bostonscientific.comand connect onLinkedInandX.

Frequently Asked Questions

When is the Boston Scientific conference call?

The conference call is scheduled for July 23, 2025, at 8:00 a.m. ET.

Who will host the conference call?

The call will be hosted by CEO Mike Mahoney and CFO Jon Monson.

How can I access the conference call?

The call will be available via a live webcast on Boston Scientific's investor website.

What will be discussed during the call?

The call will cover financial results and business highlights for Q2 2025.

ShareAdd on Google
Tags: BSX Viatris Investor Conferences Healthcare Boston Scientific Q2 2025 conference call financial results
Last updated: Jul 1, 2025

Biotech snapshot

Cash runway
$2784M liquidity · $0M/mo burn
Low dilution risk
Lead asset
Recombinant tissue plasminogen activatorPhase 3
Deep Vein Thrombosis →